NMS and genetic drug oxidation.
Otani
K
K
Kaneko
S
S
Fukushima
Y
Y
Chiba
K
K
Ishizaki
T
T
D000328:Adult; D000368:Aged; D005260:Female; D006220:Haloperidol / Q000009:adverse effects / Q000493:pharmacokinetics*; D006801:Humans; D008658:Inactivation, Metabolic / Q000235:genetics; D008297:Male; D008875:Middle Aged; D009459:Neuroleptic Malignant Syndrome / Q000097:blood / Q000235:genetics*; D010546:Perphenazine / Q000009:adverse effects / Q000493:pharmacokinetics*; D010641:Phenotype; D012307:Risk Factors
D010546:Perphenazine; D006220:Haloperidol